ExitLink

Health Care & Medical · Texas

Clinical-Stage Biopharma with a Novel, Targeted Therapy for Brain Tumors

Main Street

Asking price to be determined

Asking price
Asking price to be determined
EBITDA
—
Revenue
—
Multiple
—
Margin
—

About this business

This listing presents a development-stage biopharmaceutical company focused on a unique treatment for brain tumors. The product is a patented small-molecule agent targeting specific brain cancer cells, showing promise in pre-clinical trials and set to enter Phase 1 clinical trials in early 2026.

  • Development-stage biopharmaceutical company
  • Targeting brain tumors with novel therapy
  • Phase 1 clinical trial planned for Q1 2026
  • $4 million raised from private investors
  • Strong intellectual property protection

Business details

Category
Health Care & Medical
Business type
Main Street
Location
Texas
Listing ID
TXPH1B

Listing history

  1. Listed · Nov 12, 2026

Similar businesses for sale

See all